Kung Winston insider trades
Kung Winston has filed 19 Form 4s with the SEC that we hold, for PMV Pharmaceuticals, Inc. (PMVP) (COO, CFO), Janux Therapeutics, Inc. (JANX) (Director), Corbus Pharmaceuticals Holdings, Inc. (CRBP) (Director) and ArriVent BioPharma, Inc. (AVBP) (Chief Financial Officer). Across all of them we count 0 purchases worth $0 and 3 sales worth $320.1K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($16.0K). The largest single trade was a sale of 4,500 shares of PMV Pharmaceuticals, Inc. worth $152.2K, dated 2021-08-03. The first filing on our record is dated 2021-07-08 and the latest 2026-06-12.
PMV Pharmaceuticals, Inc. (PMVP)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-07-08 | S, sale reported on Form 4 | 4,500 | $151.9K | 2021-07-08 |
| 2021-08-03 | S, sale reported on Form 4 | 4,500 | $152.2K | 2021-08-04 |
Janux Therapeutics, Inc. (JANX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-06-10 | S, sale reported on Form 4 | 2,026 | $16.0K | 2026-06-11 |
ArriVent BioPharma, Inc. (AVBP)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1666963) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms